Stock BMRA BIOMERICA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Biomerica, Inc.

Equities

BMRA

US09061H3075

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-01 EDT 		5-day change 1st Jan Change
0.6301 USD +5.72% Intraday chart for Biomerica, Inc. -11.63% -49.59%
04-29 Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE MT
04-29 Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE
MT
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
AQ
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
CI
Biomerica Reports Third Quarter 2024 Financial Results
AQ
Biomerica provides update on inFoods® IBS expansion
AQ
Biomerica Provides Update on inFoods IBS Expansion
CI
Biomerica Reports Third Quarter 2024 Financial Results
AQ
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024
CI
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
AQ
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
AQ
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board
CI
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
AQ
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors
CI
Biomerica Reports Second Quarter 2024 Financial Results
AQ
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023
CI
Top Premarket Decliners
MT
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test
DJ
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
AQ
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria
CI
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BMRA Stock
  4. News Biomerica, Inc.